Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04939701
Title Study of ASP0739 Alone and With Pembrolizumab in Advanced Solid Tumors With NY-ESO-1 Expression Participants
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Astellas Pharma Global Development, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
University of Miami Miami Florida 33136 United States Details
Northwestern University Robert H. Lurie Comprehensive Cancer Center Chicago Illinois 60611 United States Details
The University of Chicago Medicine Chicago Illinois 60637 United States Details
NYU Perlmutter Cancer Center New York New York 10016 United States Details
Brown University Providence Rhode Island 02903 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field